RXRX Competitors & Alternatives
Compare Recursion Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RXRX
Main Stock$2.93
Tradestie Score
50
Market Cap
$2.23B
Revenue Growth
-0.6%
Analyst Upside
+126.7%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MNKD
Mannkind Corporation
|
$3.09
|
$1.65B | - | 57 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$33.09
|
$1.63B | - | 58 | Compare |
|
BHVN
Biohaven Ltd.
|
$8.76
|
$1.57B | - | 57 | Compare |
|
VCEL
Vericel Corporation
|
$33.03
|
$1.56B | 77.0 | 58 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$86.16
|
$1.55B | - | 58 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$30.09
|
$1.55B | 12.4 | 60 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$30.40
|
$1.55B | - | 61 | Compare |
|
NVAX
Novavax Inc
|
$9.06
|
$1.54B | - | 58 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.28
|
$1.50B | 7.1 | 59 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$38.69
|
$1.50B | - | 56 | Compare |
More RXRX Analysis
Data updated: May 15, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry